Drug Product
Advanced Modalities
Analytical & Bioanalytical Services
Company Overview
About
EirGenix is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:Taiwan
Founded:2002
Employees:1,555
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
North America
Europe
International Regulatory
EU GMP Certificates
2
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval C1FAEL
Health Canada · #APR-MRGC29LL · 2020-12-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-KIVCNE1J
Issued: 2020-06-25
Expires: 2025-04-10
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-2PZOIPP0
Issued: 2020-06-26
Expires: 2025-09-11
Loading CDMO intelligence...
Key facts about EirGenix
- EirGenix is headquartered in Taiwan.
- EirGenix was founded in 2002.
- EirGenix has 1,555 employees.
- EirGenix's capabilities include Oral Solid Dose, Solid Dose Manufacturing and Formulation Development.
Find CDMOs like EirGenix
Directory pages this company appears in, each with the full list of matching manufacturers.